The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...
2d
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback